創元科技(000551.SZ):蘇州軸承生產的各類軸承系列產品還應用於高端裝備、機器人、減速機等領域
格隆匯6月28日丨有投資者向創元科技(000551.SZ)提問,“公司除了蘇軸股份與蘇州金龍還有哪些在新能源汽車零部件的投資與產業佈局?另外在人工智能與機器人方面,公司有哪些佈局?”
創元科技回覆稱,公司控股子公司蘇州軸承生產的各類軸承系列產品廣泛應用於汽車的轉向系統、制動系統、扭矩管理系統、新能源電驅系統、發動機、變速箱和空調壓縮機等總成,同時還應用於工業自動化、高端裝備、機器人、工程機械、減速機、液壓傳動系統、家用電器、電動工具、紡機、農林機械、航空航天、國防等領域。未來,公司將持續深耕主業,努力做好經營管理,不斷提升盈利能力和可持續增長能力,做好股東回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.